Shannon L. Gillespie

Dr. Shannon L. Gillespie brings unique perspective and expertise to her research into maternal-infant health. She pairs clinical experience with scientific expertise in translational psychoneuroimmunology, making her one of a handful of scientists working to optimize maternal-infant well-being and prevent maternal and infant morbidity and mortality from this unique perspective. More specifically, Dr. Gillespie’s expertise allows her to both scientifically discover and clinically optimize novel methods for psychoneuroimmune monitoring, transforming our ability to predict and prevent complications among antepartum, intrapartum and postpartum populations.
Dr. Gillespie used her 20 years of experience in various research settings to lead two NIH-funded projects as Principal Investigator, and she has filed two patents on her novel methods. She also provides consultation to teams incorporating psychoneuroimmune monitoring into their work among diverse populations (e.g., AHA SFRN) and is passionate about mentoring students of diverse disciplines and inspiring them to bravely tackle our nation’s most complex problems using their unique skillsets.
This decorated nurse scientist earned her BA in psychology from Ohio University and her MS and PhD in nursing from The Ohio State University. She has won several university, regional and national research honors and was inducted as a Fellow of the American Academy of Nursing in 2024.
Laboratory and study websites:
- Maternal Immune Monitoring Laboratory
- The MOMI Study (NIH R01NR021111)
- The PROMIS Study (NIH R01HD110503)
View publications
View NIH-funded research projects
News
College ranks #12 overall and #1 among Big Ten and Ohio colleges of nursing
New rankings measuring National Institutes of Health (NIH) grant funding among colleges of nursing nationwide show that The Ohio State University College of Nursing maintained its strong national standing and leadership in nursing research.
Finding suggests need for education about tech's reliability
The use of fertility-tracking technology increased in some states after the U.S. Supreme Court overturned Roe v. Wade despite warnings that reproduction-related data might not be secure, a new study has found.